Vestiage, Inc. (stock symbol "VEST") a publicly traded anti-aging lifestyle company focused on science-based research and development, sales and marketing of premium branded highly effective anti-aging cosmeceuticals and nutraceuticals, announced today that it has awarded the exclusive Vestiage territories of Boston, New York City, and Miami/Palm Beach to Beacon Health of Boston. Beacon Health will begin selling the Reluma brand to select premium and prestige salons, spas, resorts, physicians, skin care boutiques and select retailers immediately, Reluma is a revolutionary facial care product using the latest human stem cell technology. Reluma is manufactured in the Reluma Laboratory in California, USA.
"I have known the owners of Beacon Health for over 30 years," said Scott Kimball, CEO of Vestiage, Inc. "These territories are significant and I am pleased to have Beacon handling them and building distribution for our Reluma brand throughout each of them."
The three territories are estimated to cover more than 10,000 potential customers and generate more than $ 40 million in wholesale revenue to Vestiage.
No comments:
Post a Comment